Innovating Works

JANSSEN BIOLOGICS BV

Desconocido
eCHO Systems: Enhancing CHO by Mammalian Systems Biotechnology eCHO systems JANSSEN BIOLOGICS BV participó en un H2020 H2020-MSCA-ITN-2014 Chinese hamster (CHO) ovary cells are the production host for a +50 billion €/yr biopharmaceuticals market. Current CHO production platforms...
2014-12-05 - 2018-12-31 | Financiado
U-BIOPRED: Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes JANSSEN BIOLOGICS BV participó en un FP7 Rationale The inability of pre-clinical studies to predict clinical efficacy is a major bottleneck in drug development. In severe asthma thi...
Financiado
BTCURE: BeTheCuRE JANSSEN BIOLOGICS BV participó en un FP7 BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal model...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.